ClinicalTrials.gg
RecruitingNCT06638645PROTRACTUpdated Jan 15, 2025

Prolonged Hospital Stay After Thoracoscopic Anatomical Lung Resections

An observational study in Minimally Invasive Surgical Procedures, VATS and RATS Surgery, sponsored by University Hospital, Ghent. Recruiting at 2 sites in Belgium. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2025-01-15.

Primary conditionPain, PostoperativeRegistry: Postoperative ComplicationsReclassifiedWhy we changed it
Registry
Postoperative Complications — the first condition term the registry derived for this study.
ClinicalTrials.gg
Pain, Postoperative
Why
  1. The study's listed conditions name Pain, Postoperative, a narrower term within Postoperative Complications.
Confidence
High: the new condition is named in the study's own listed conditions. Of 351 hand-checked studies reclassified this way, 68% were exactly right and 84% in the right disease family; the registry's first term was right for 5% (measured 2026-10-21). How we classify →
Wrong?
Tell us the study's main condition →

Sponsored by University Hospital, Ghent · Observational

How we know

From the registry’s dates

  • Primary completion was expected by Dec 2025, 10 months ago, but the record still lists the study as recruiting.
  • Started Nov 2024; still recruiting 2 years later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
140
Ages
18 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 72 studies in Pain, Postoperative with a site in Belgium — 12 open to participants now, 15 under way, none of them phase 3. Pain, Postoperative · Belgium.

Planned enrollment
13th of 17
140 · median 250
Started
2024
with 1 other
Observational
17 of 72
5 open now
Primary completion
2025-12
later than 1 of 14 live
Registered
60th of 72
by date
Lead sponsor
7 of 72
University Hospital, Ghent

Among the 72 studies in Pain, Postoperative with a site in Belgium, this one is the 13th largest by planned enrollment of the 17 observational ones that give a count, is one of 2 that started in 2024, is one of 17 observational ones, reaches primary completion later than 1 of the 14 other live ones, and was the 60th registered.

Pain, Postoperative

5,680 studies on the registry are indexed under Pain, Postoperative; 1,243 are open to participants now.

Browse Pain, Postoperative studies →

Open to participants now

12 of the 72 studies in Pain, Postoperative with a site in Belgium are open now. Recruiting first, the newest first:

6 more — sign in →

All 12 open studies →

A study can be open while its sites in Belgium have not opened yet or have stopped. Only those recruiting at a site in Belgium →

Who these studies take

Of the 678 Pain, Postoperative studies recruiting now, 239 (35%) set no upper age limit and 329 (49%) stop at 75 or younger; 74 take children under 18; 129 take healthy volunteers.

This study: 18 Years and older · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 72 studies in Pain, Postoperative with a site in Belgium, or all of them as a file.
02

Study summary

In this study, the reasons for prolonged hospital stay after thoracoscopic (video- or robot-assisted) anatomical lung resections are investigated. Currently, whenever possible, these anatomical lung resections are performed thoracoscopically, as they offer significant improvements in terms of postoperative pain, number of postoperative complications, rehabilitation, tolerance for adjuvant chemotherapy, and length of hospital stay. The development of an 'Enhanced Recovery After Surgery' (ERAS) protocol for lung surgery has further reduced hospital stay and the need for opioids for analgesia. Despite the optimal implementation of the ERAS protocol, there are still patients who need to stay in the hospital longer than the median. The aim of this research is to investigate the reasons for this.

03

Conditions studied

  • Minimally Invasive Surgical Procedures
  • VATS
  • RATS Surgery
  • Pulmonary Lobectomy
  • Pulmonary Segmentectomy
  • Air Leakage
  • Postoperative Complication
  • Pain Postoperative

Browse trials for

04

In context

Pain, Postoperative Reclassified

5,680 studies on the registry are indexed under Pain, Postoperative; 1,243 are open to participants now.

This study's planned enrollment of 140 is above the median of 102 across 685 observational studies indexed under Pain, Postoperative.

Browse Pain, Postoperative studies →

Lead sponsor

University Hospital, Ghent is the lead sponsor of 689 studies on the registry; 157 are open to participants now.

Of its 5 completed or terminated interventional studies of FDA-regulated products, 4 (80%) have results posted.

Compared within Pain, Postoperative, this study's primary condition as ClinicalTrials.gg classifies it; the registry's first condition term is Postoperative Complications. The counts are of registry records indexed under each term, refreshed daily. How we classify →

05

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Patients scheduled for thoracoscopic anatomical lung resection. An estimated 136 patients should be included after power calculation

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Patients referred for elective minimally invasive (uniportal or multiportal video- or robot-assisted) anatomical lung resection (lobectomy or segmentectomy)
  • obtained pre-operatively
  • Age 18 years or older

Exclusion criteria

Exclusion Criteria:

  • Patients younger than 18 years old
  • Traumatic event as indication for lung resection
  • Non-anatomical lung resections
  • Thoracotomy
  • Patients already hospitalized for other pathologies, pre-existent and not related to the lung surgery
  • Urgent/emergency procedures
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

06

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
140 participants (estimated)
Target follow-up
2 Months
Patient registry
Yes

Groups and cohorts

  • Patients undergoing a minimally invasive anatomical lung resection

    Patients undergoing a minimally invasive anatomical lung resection, receiving perioperative care according to the ERAS protocol for Lung Surgery

    Procedure: VATS/RATS anatomical lung resection

Interventions

  • ProcedureVATS/RATS anatomical lung resection

    Perioperative care according to the ERAS protocol for lung surgery

    Also known as: VATS lobectomy, RATS lobectomy, VATS segmentectomy, RATS segmentectomy

07

What researchers measure

Primary outcomes

  1. Length of hospital stay (days)

    The primary objective is to investigate the length of hospital stay of patients undergoing minimally invasive thoracoscopic anatomical lung resection with peri-operative care according to the Enhanced Recovery After Surgery (ERAS) protocol for lung surgery

    Time frame: immediately after surgery until hospital discharge (1 week on average), up to 3 months

Secondary outcomes

  1. Reasons for delayed discharge (more than 2 days postoperatively) identified through daily questionnaires and review of medical records.

    * Postoperative pain (NRS) * Postoperative nausea and vomiting (yes/no) * Air leak duration (days)

    Time frame: immediately after surgery until hospital discharge (1 week on average), up to 3 months

  2. Number, frequency and severity of postoperative complications during hospital stay.

    Time frame: immediately after surgery until hospital discharge (1 week on average), up to 3 months

08

Study locations

2 of 2 sites recruiting
09

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

10

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Nov 2024 (actual). Primary completion is estimated for Dec 2025, 13 months after the start.

Of 392 non-industry observational studies under Pain, Postoperative, half reached primary completion within 12 months of starting (the median), counting those still running; a quarter within 5 and three quarters within 32. This study's planned 13 months is close to that.

Counting every sponsor, half of 396 studies reached it within 13 months; a quarter within 6 and three quarters within 33.

How these figures are worked out, and which studies are left out of them.

Registered
Oct 1, 2024
First posted
Oct 15, 2024
StartActual
Nov 12, 2024
Primary completionEst.
Dec 31, 2025
CompletionEst.
Dec 31, 2025
Last update
Jan 15, 2025
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jan 15, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
11

Registry details

Key details

Study ID
NCT06638645
Collaborators
AZ Sint-Lucas Brugge
Responsible party
DienstThoracaleEnVasculaireHeelkunde (Clinical professor, University Hospital, Ghent) — Principal investigator
First posted
Oct 15, 2024
Start date
Nov 12, 2024
Primary completion
Dec 31, 2025 (estimated)
Completion
Dec 31, 2025 (estimated)
Last update
Jan 15, 2025

Study contacts

Liesbeth Desender, MD, PhD
Contact
Liesbeth.Desender@uzgent.be
3293326148

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion